24 children, suffering from anemia secondary to ESRD and on peritoneal dialysis, aged 3 months to 18 years, were treated with SC r-HuEPO, in varying doses, depending on the Hb levels achieved with each dose. This evidence concerns the gene GSTM1 and anemia (phenotype).